Indication
Recurrent Follicular Helper T-Cell Lymphoma
1 clinical trial
1 product
Clinical trial
A Phase I Trial of MEDI-570 in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL)Status: Active (not recruiting), Estimated PCD: 2023-08-04
Product
MEDI-570